Clinical Patterns and Associated Conditions
At a Glance
Pyoderma gangrenosum has four skin patterns: classic ulcerative, bullous, pustular, and vegetative. Some patterns are associated with bowel disease, arthritis, or blood disorders, but a skin pattern alone does not prove another condition; evaluation uses symptoms, an exam, and routine tests.
While Pyoderma Gangrenosum (PG) is often first noticed as a painful skin lesion, it is frequently a “window” into what is happening inside the rest of your body. Research shows that approximately 57% of people diagnosed with PG have an associated systemic (body-wide) medical condition [1]. Understanding the specific way your PG appears can help your care team identify whether another health issue needs attention. However, it is important to remember that these are associations, not proof of causation. An association with PG does not mean a patient definitely has leukemia, MDS, IBD, or arthritis. Evaluation is tailored to symptoms, examination, age, and routine laboratory findings, and many patients have no identified associated disease.
The Four Major Patterns
Dermatologists categorize PG into four main clinical subtypes based on how the lesions look and behave. While they all involve immune system overactivity, they can signal different things about your overall health. Subtypes can overlap, but identifying the primary pattern is helpful.
- Classic Ulcerative PG: This is the most common form. It typically begins as a small, painful red bump or blood-filled blister that rapidly breaks down into a deep ulcer [2]. These ulcers often have “undermined” edges—meaning the wound is larger underneath the surface than it appears from above—and a distinct purple or violet border [3]. It most often appears on the legs but can occur anywhere [4].
- Bullous (Atypical) PG: This subtype is characterized by the rapid appearance of painful, blue-gray blisters (bullae) [5]. It tends to be shallower than the classic ulcerative type but can spread quickly [6].
- Pustular PG: This version presents as clusters of small, pus-filled bumps (pustules) that do not contain bacteria [7]. It is often associated with intense inflammation and may stay as pustules for a long time before potentially turning into ulcers [8].
- Vegetative (Superficial Granulomatous) PG: This is a milder, slower-growing version. The lesions are usually less painful and more superficial, appearing as firm, crusty plaques rather than deep holes [9]. Unlike the other types, this form is only rarely linked to other internal diseases [10].
The Connection to Systemic Health
Because PG is an inflammatory disorder, it may be associated with other conditions that cause high levels of inflammation in the body.
Inflammatory Bowel Disease (IBD)
There is a strong link between PG and digestive health. Roughly 18% to 41% of patients with PG also have Crohn’s disease or ulcerative colitis, though estimates depend on the cohort studied [1][11]. In children, this connection is even stronger; one study found that over half of pediatric PG patients had Crohn’s disease [12]. Pustular PG, in particular, is frequently seen in people experiencing a “flare” of their bowel disease [12].
Inflammatory Arthritis
Joint issues are another common companion to PG, affecting about 13% to 20% of patients [1][11]. Interestingly, joint symptoms like stiffness and swelling often appear long before the skin lesions do—sometimes by a median of 10 years [13]. Rheumatoid arthritis is the most frequent association in this category [13].
Hematologic (Blood) Disorders
The bullous (blistered) subtype of PG carries a specific and important association with blood disorders, particularly myelodysplastic syndrome (MDS) and certain types of leukemia [5][14]. In these cases, the skin reaction may be an early sign of a bone marrow issue [15]. A bullous pattern does not definitively diagnose a blood disorder by itself, but its presence often prompts doctors to perform a more detailed blood evaluation like a CBC [6][5].
| Subtype | Key Feature | Common Association [16][1] |
|---|---|---|
| Classic | Deep ulcer, violet border | IBD, Arthritis |
| Bullous | Painful blue-gray blisters | Blood disorders (MDS, Leukemia) |
| Pustular | Clusters of sterile pustules | IBD flares |
| Vegetative | Shallow, crusty plaques | Rarely linked to other disease |
Understanding these patterns allows you and your doctor to look beyond the skin and ensure that any underlying conditions driving the inflammation are appropriately evaluated.
Common questions in this guide
What are the four clinical patterns of pyoderma gangrenosum?
Does having pyoderma gangrenosum mean I have another disease?
Which health conditions are most often linked to PG?
Why might someone with bullous PG need a blood test?
Can joint or digestive symptoms be related to PG?
What should I tell my doctor about a new PG lesion?
Questions to Ask Your Doctor
Curated prompts to bring to your next appointment.
- 1.Which of the four clinical patterns does my skin lesion most closely match?
- 2.Given that more than half of people with PG have an underlying condition, what basic tests (like blood work) should we do to check for them?
- 3.I have a history of [joint pain/stomach issues/fatigue]; could this be linked to my skin symptoms?
- 4.If my lesions are the bullous (blistered) type, should I have a CBC or see a hematologist for a specialized blood evaluation?
- 5.Does the timing of my symptoms suggest that one condition might be related to the other?
Questions For You
Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.
References
References (16)
- 1
Underlying Systemic Diseases in Pyoderma Gangrenosum: A Systematic Review and Meta-Analysis.
Kridin K, Cohen AD, Amber KT
American journal of clinical dermatology 2018; (19(4)):479-487 doi:10.1007/s40257-018-0356-7.
PMID: 29721816 - 2
Pyoderma gangrenosum - a guide to diagnosis and management .
George C, Deroide F, Rustin M
Clinical medicine (London, England) 2019; (19(3)):224-228 doi:10.7861/clinmedicine.19-3-224.
PMID: 31092515 - 3
Diagnostic Criteria of Ulcerative Pyoderma Gangrenosum: A Delphi Consensus of International Experts.
Maverakis E, Ma C, Shinkai K, et al.
JAMA dermatology 2018; (154(4)):461-466 doi:10.1001/jamadermatol.2017.5980.
PMID: 29450466 - 4
Pyoderma Gangrenosum: A Critical Appraisal.
Shavit E, Alavi A, Sibbald RG
Advances in skin & wound care 2017; (30(12)):534-542 doi:10.1097/01.ASW.0000526605.34372.9e.
PMID: 29140836 - 5
Bullous pyoderma gangrenosum as a predictor of hematological malignancies.
Vacas AS, Bollea-Garlatti ML, Torre AC, Galimberti RL
Anais brasileiros de dermatologia 2018; (93(1)):133-134 doi:10.1590/abd1806-4841.20187031.
PMID: 29641716 - 6
Bullous Pyoderma Gangrenosum With Subungual Involvement Associated With Ulcerative Colitis.
Aktaş Karabay E, Aksu Cerman A, Kıvanc Altunay İ, Yalçın Ö
The American Journal of dermatopathology 2017; (39(6)):476-478 doi:10.1097/DAD.0000000000000801.
PMID: 27893467 - 7
Decoding the Histopathology of Pustular Pyoderma Gangrenosum: A Multidisciplinary Approach to Diagnosis.
Bavikar R, Singh D
Cureus 2024; (16(8)):e67059 doi:10.7759/cureus.67059.
PMID: 39286710 - 8
A Case of Pustular Pyoderma Gangrenosum Misdiagnosed as Acute Febrile Neutrophilic Dermatosis in a Pediatric Patient.
Yang X, Wu Y, Jiang F, Deng D
Clinical, cosmetic and investigational dermatology 2024; (17()):493-498 doi:10.2147/CCID.S449404.
PMID: 38435844 - 9
A perplexing case of superficial granulomatous pyoderma with sporotrichoid-like distribution.
Parker J, Liszewski W, Merten AH, et al.
Dermatology online journal 2020; (26(6)).
PMID: 32815693 - 10
Superficial Granulomatous Pyoderma Successfully Treated with Intravenous Immunoglobulin.
Borg Grech S, Vella Baldacchino A, Corso R, et al.
European journal of case reports in internal medicine 2021; (8(9)):002656 doi:10.12890/2021_002656.
PMID: 34671571 - 11
The Association of Age With Clinical Presentation and Comorbidities of Pyoderma Gangrenosum.
Ashchyan HJ, Butler DC, Nelson CA, et al.
JAMA dermatology 2018; (154(4)):409-413 doi:10.1001/jamadermatol.2017.5978.
PMID: 29450453 - 12
Pediatric Pyoderma Gangrenosum: A Retrospective Review of Clinical Features, Etiologic Associations, and Treatment.
Schoch JJ, Tolkachjov SN, Cappel JA, et al.
Pediatric dermatology 2017; (34(1)):39-45 doi:10.1111/pde.12990.
PMID: 27699861 - 13
Inflammatory arthritis-associated pyoderma gangrenosum: a systematic review.
Sawka E, Zhou A, Latour E, et al.
Clinical rheumatology 2021; (40(10)):3963-3969 doi:10.1007/s10067-021-05768-7.
PMID: 34002351 - 14
Pyoderma gangrenosum in hematologic malignancies: A systematic review.
Montagnon CM, Fracica EA, Patel AA, et al.
Journal of the American Academy of Dermatology 2020; (82(6)):1346-1359 doi:10.1016/j.jaad.2019.09.032.
PMID: 31560977 - 15
Bullous Variant of Pyoderma Gangrenosum in a Patient with Acute Myeloid Leukemia.
Kwon CI, Lee GW, Kim CY
Annals of dermatology 2022; (34(3)):212-215 doi:10.5021/ad.2022.34.3.212.
PMID: 35721340 - 16
Management of Idiopathic Pyoderma Gangrenosum With Azathioprine As the Primary Adjunct in an Asian Man: A Case Report.
Nazir A, Zafar A
Cureus 2022; (14(5)):e25177 doi:10.7759/cureus.25177.
PMID: 35746991
This page is for informational purposes only and does not constitute medical advice. A dermatologist or other clinician should interpret your symptoms and decide whether testing for an associated condition is appropriate.
Get notified when new evidence is published on Pyoderma gangrenosum.
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.